INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo BROOKLAX® PILLS
SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME:
(and dosage form)

BROOKLAX® PILLS

COMPOSITION:
Each tablet contains:
        Phenolphthalein (yellow)        192 mg
        Aloin        16 mg
        Oleoresin Capsicum        0,6 mg

PHARMACOLOGICAL CLASSIFICATION:
A11.5 - Laxatives.

PHARMACOLOGICAL ACTION:
Brooklax Pills have laxative properties.

INDICATIONS:
Brooklax Pills are recommended for relief from constipation, infrequent, difficult or painful passage of stools.

CONTRA-INDICATIONS:
This medicine should not be taken by patients with intestinal obstruction, in the presence of abdominal pain, nausea or vomiting; nursing mothers or pregnant women.

WARNINGS:
1.        If a skin rash appears or if a patient is known to be sensitive in any other, regard to phenolphthalein, this medicine should be discontinued immediately and this or any other preparation containing phenolphthalein should not be used in future.
2.        Frequent a prolonged use of this preparation may result in dependence on laxatives.
3.        Do not use for longer than one week except on the advice of a doctor.
4.        It you have noticed a sudden change in bowel habits that has persisted for a period of greater than two weeks, consult a doctor before using the laxative.
5        Toxic epidermal necrolysis may infrequently occur and may be life-threatening.

DOSAGE AND DIRECTIONS FOR USE:
ADULTS ONLY: One or two tablets at night as required
DO NOT EXCEED THE STATED DOSE.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Abdominal cramps may occasionally occur. The following side effects of phenolphthalein may occur infrequently:
Excessive laxation or electrolyte depletion with high doses, skin reactions, including non-specific rashes and pigmentation; toxic epidermal necrolysis.
Aloin may cause renal irritation.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Derangement of fluids and electrolytes; shock; intense metabolic acidosis; convulsions; acute renal failure and a possible fatal outcome.
In case of accidental overdosage, consult your doctor immediately or go to the nearest hospital.

IDENTIFICATION:
Brown sugar-coated tablet.

PRESENTATION:
Boxes containing 10 tablets in sealed celophane packets.

STORAGE INSTRUCTIONS:
Store in a cool (below 25°C) dry place.
Keep out of reach of children.

REGISTRATION NUMBER:
E1392 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Group Laboratories SA (Pty) Limited
21 Wrench Road
Isando
Transvaal

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
MAY 1990

809 4503 01        Rosside 22216

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2003